Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk PatientsJeffrey J. Popma, Michael J. Reardon, Judah Askew et al.|New England Journal of Medicine|2019Cited by 3.6k
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic StenosisTed Feldman, Keith D. Dawkins, Michael J. Reardon et al.|JAMA|2018Cited by 168
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High RiskDaniel O’Hair, Michael J. Reardon, Steven J. Yakubov et al.|JAMA Cardiology|2022Cited by 114
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsJohn K. Forrest, Michael J. Reardon, G. Michael Deeb et al.|Journal of the American College of Cardiology|2022Cited by 91
Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trialBasel Ramlawi, John K. Forrest, G. Michael Deeb et al.|Journal of Thoracic and Cardiovascular Surgery|2024Cited by 5